BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3021067)

  • 1. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
    Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
    Kelly K; Pan Z; Wood ME; Murphy J; Bunn PA
    Clin Cancer Res; 1999 Nov; 5(11):3419-24. PubMed ID: 10589753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adriamycin, cisplatin, and etoposide combination chemotherapy for small cell lung cancer].
    Irino S; Fujita J; Yamaji Y; Futami H; Hashimoto Y; Bungo M; Iuchi Y; Kamei M; Nakamura H; Hata Y
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2263-7. PubMed ID: 2544150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A combination phase II study of adriamycin, CDDP and etoposide in small cell lung cancer].
    Honda R; Fujita A; Inoue Y; Asakawa M; Tagaki S; Ohshima S; Suzuki A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):375-9. PubMed ID: 2155585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
    Bunn PA; Kelly K
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-144-S12-148. PubMed ID: 9331140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A pilot study of etoposide, split-dose cisplatin and THP in small cell lung cancer].
    Matsui Y; Satake N; Kusume K; Kado M; Ohshima S; Yamamoto Y; Ishida H; Matsubara Y; Ikeda S
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2567-72. PubMed ID: 1660701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
    Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
    Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cisplatin, adriamycin and VP-16 (CAV) in the treatment of small cell carcinoma of the lung].
    Yokoyama A; Kinameri K; Kurita Y
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2573-8. PubMed ID: 6095762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA; Kelly K
    Semin Oncol; 1996 Dec; 23(6 Suppl 16):11-5. PubMed ID: 9007114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
    Bunn PA; Kelly KL
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):54-8; discussion 59-60. PubMed ID: 7481862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.
    Dimitroulis J; Rapti A; Stathopoulos GP; Rigatos S; Stathopoulos J; Koutantos J; Athanasiadis A; Tsikritsaki K; Karaindros D; Katis K; Antoniou D; Toumbis M; Giamboudakis P
    Oncol Rep; 2008 Oct; 20(4):879-84. PubMed ID: 18813830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
    Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
    Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy.
    Hainsworth JD; Greco FA
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial evaluating continuous infusion of etoposide, cisplatin, and hexamethylmelamine in extensive-disease small cell carcinoma of the lung.
    Remick SC; Neville AJ; Willson JK
    Cancer Treat Rep; 1987 Jun; 71(6):575-80. PubMed ID: 3034422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung.
    Porter LL; Johnson DH; Hainsworth JD; Hande KR; Greco FA
    Cancer Treat Rep; 1985 May; 69(5):479-81. PubMed ID: 2988773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.